Comment by LarsDu88

As someone who works in the AI/ML field, but somewhat in a biomedical space, this is promising to hear.

The core technology is becoming commoditized. The ability to scale is also becoming more and more commoditized by the day. Now we have the capability to truly synthesize the world's biomedical literature and combine it with technologies like single cell sequencing to deliver on some really amazing pharmaceutical advances over the next few years.